PZ CUSSONS PLC
29 January 2008
29 JANUARY 2008
PZ CUSSONS PLC
ACQUISITION OF THE SANCTUARY BRAND AND SPA FOR £75M
PZ Cussons Plc, a leading consumer products group in personal care and household
products, announces the acquisition of The Sanctuary Spa Holdings Limited
('Sanctuary Spa Holdings') for a consideration of £75m in cash (on a cash and
debt free basis).
Sanctuary Spa Holdings comprises two elements: a premium range of beauty and
body care products sold under The Sanctuary brand, representing some 70% of
revenue, and The Sanctuary Spa, the UK's largest day spa, based in London's
Covent Garden.
Over 90% of The Sanctuary personal care products are sold in the UK market where
the range has grown to become one of the leading beauty and body care brands in
this dynamic and fast growing segment. The range includes shower and bath
products, salt scrubs, body lotions, body oils and a small but growing skincare
line.
The exclusively female Sanctuary spa attracts some 64,000 visitors per year, and
plays an important part in the development of The Sanctuary range of products
both through the expertise of the spa personnel and customer feedback.
As at the year ended 31st August 2007, Sanctuary Spa Holdings had gross assets
of £26.9m, including £15.8m of goodwill. Revenue and earnings before
depreciation, amortisation, interest and tax for the year ended 31st August 2007
were £26.3m and £6.2m respectively. Profit before tax for the year ended 31st
August 2007 was £3.9m. The business is being acquired on a cash and debt free
basis.
Alex Kanellis, Group Chief Executive of PZ Cussons Plc, said:
'The Sanctuary business represents an excellent strategic opportunity for PZ
Cussons, giving us a greater presence in the premium segment of the UK's
personal care market through an established and well respected brand. It further
strengthens our UK position as leader in the Personal Wash category, and
bolsters our developed market presence thereby enhancing the balance of the
Group.
'We see considerable opportunities to create further value from The Sanctuary
business, through combining our new product and brand development expertise with
theirs, developing the brand's international sales, and exploring opportunities
to develop the spa concept further. There are also synergies to be derived,
particularly in the area of supply chain.
'Following this acquisition our balance sheet remains strong, giving flexibility
for further investment opportunities as they arise.'
PZ Cussons Plc's interim results for the half year to 30th November 2007 have
been published today - see separate announcement.
- Ends -
Press Enquiries:
PZ Cussons Graham Calder (Deputy Chairman)
Brandon Leigh (Finance Director)
Hogarth Partnership John Olsen, Sarah MacLeod, Sarah Richardson
020 7357 9477
On 29th and 30th January c/o Hogarth.
After 30th January to Graham Calder or Brandon Leigh on 0161 491 8000.
An analysts' presentation covering PZ Cusson's interim results and the
acquisition will be held on 29th January 2008 at 9.30am at the offices of JP
Morgan Cazenove, 20 Moorgate, London, EC2R 6DA.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.